In 2024, we celebrated our 25th anniversary. That's 25 years of smarter studies, global impact and better health. '25 at 25' is a series of articles highlighting 25 of our major achievements in that time.

Latest News

The key guide to estimating hazard ratios from published data gets a major update

Comprehensively updated guidance and associated calculations spreadsheet are valuable new tools for all those conducting meta-analyses based on published time-to-event data.

23 Apr

New guidance on addressing barriers to sharing trial results with participants

The new guidance summarises the discussion from a workshop for trial funders, and signposts relevant resources and guidance.

03 Apr

The STAMPEDE prostate cancer trial wins NIHR Impact Prize

The NIHR Impact Awards celebrate research that has had an outstanding impact beyond academia.

25 Mar

STOPCAP study finds that most men with advanced prostate cancer benefit from new-generation hormone therapy drugs



New results from a meta-analysis by the STOPCAP Collaboration were presented at the American Society of Clinical Oncology Genitourinary 2025 Meeting.

13 Feb

More News

Research Themes

Cancer cells

Cancer

Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types

 

Infections

Major international clinical trials answering questions of global public health significance

Neurodegenerative diseases

New generation of innovative multi-arm multi-stage trials to identify and test new therapeutic treatments in neurodegenerative diseases (NDD)

Methodology

Development of methods with direct impact on the design, conduct and analysis of studies

 

 

Other Research & Policy

This section will capture projects outside the current QQR themes

Latest Podcasts

 

 

Latest Videos